FDA Inspection 1294096 — Sixarp, LLC
The FDA completed an inspection of Sixarp, LLC on November 19, 2025 in Byron Center, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 19, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Byron Center, MI (United States)